1975
DOI: 10.1136/bjo.59.12.725
|View full text |Cite
|
Sign up to set email alerts
|

Nebcin in the treatment of experimental Pseudomonas keratitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1979
1979
2000
2000

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 5 publications
(2 reference statements)
0
1
0
Order By: Relevance
“…The comparative in vivo studies that have been done indicate that there is no notable difference between tobramycin and gentamicin against Enterobacteriaceae [11,15,16], and that tobramycin is somewhat more effective than gentamicin in treating infections caused by Pseudomonas [1,5,6,13,14], If this is confirmed by further in vivo studies, it will indicate that the PDM medium is not suitable for sensitivity testing of Enterobacteriaceae and Pseudomonas spp. against the two most commonly used aminoglycosides.…”
Section: Discussionmentioning
confidence: 96%
“…The comparative in vivo studies that have been done indicate that there is no notable difference between tobramycin and gentamicin against Enterobacteriaceae [11,15,16], and that tobramycin is somewhat more effective than gentamicin in treating infections caused by Pseudomonas [1,5,6,13,14], If this is confirmed by further in vivo studies, it will indicate that the PDM medium is not suitable for sensitivity testing of Enterobacteriaceae and Pseudomonas spp. against the two most commonly used aminoglycosides.…”
Section: Discussionmentioning
confidence: 96%